Evidence map›Paper›PMID 25243985›Full record

ReviewBiological reviews of the Cambridge Philosophical Society2015

The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.

Anna Stincone, Alessandro Prigione, Thorsten Cramer, Mirjam M C Wamelink, Kate Campbell, Eric Cheung, Viridiana Olin-Sandoval, Nana-Maria Grüning, Antje Krüger, Mohammad Tauqeer Alam and 5 more

Open access · hybridAbstract readReview
In one paragraph

Review in Biological reviews of the Cambridge Philosophical Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 804 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
804citing papers in PubMed, 2 pooled it
24.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

804 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,479 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Metabolic profiling analysis of cytochrome bMetabolomics : Official journal of the Metabolomic Society · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

744 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Anna StinconeDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Alessandro PrigioneMax Delbrueck Centre for Molecular Medicine, Robert-Rössle-Str. 10, 13092 Berlin, Germany.
Thorsten CramerDepartment of Gastroenterology and Hepatology, Molekulares Krebsforschungszentrum (MKFZ), Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.
Mirjam M C WamelinkMetabolic Unit, Department of Clinical Chemistry, VU University Medical Centre Amsterdam, De Boelelaaan 1117, 1081 HV Amsterdam, The Netherlands.
Kate CampbellDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Eric CheungCancer Research UK, Beatson Institute, Switchback Road, Glasgow G61 1BD, U.K.
Viridiana Olin-SandovalDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Nana-Maria GrüningDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Antje KrügerMax Planck Institute for Molecular Genetics, Ihnestr 73, 14195 Berlin, Germany.
Mohammad Tauqeer AlamDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Markus A KellerDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Michael BreitenbachDepartment of Cell Biology, University of Salzburg, Hellbrunnerstrasse 34, A-5020 Salzburg, Austria.
Kevin M BrindleDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Joshua D RabinowitzDepartment of Chemistry, Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, 08544 NJ, U.S.A.
Markus RalserDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, U.K.
Amsterdam UMC Location VUmc · NLCharité - Universitätsmedizin Berlin · DEMax Delbrück Center · DEMax Planck Institute for Molecular Genetics · DEUniversity of Salzburg · AT

Funding

Tumor cell metabolism in actionR01CA163591 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI JOSHUA D RABINOWITZ, Eileen P. White · 2012 to 2026
$7.0M
Mechanisms and consequences of metabolic manipulation by human cytomegalovirusR01AI097382 · NIAID · PRINCETON UNIVERSITY · PI RABINOWITZ, JOSHUA D, SHENK, THOMAS E · 2012 to 2015
$2.2M
Cancer Research UK 16465Cancer Research UK 17242European Research Council 260809European Research Council 322842Medical Research Council MC_UP_1202/8NCI NIH HHS R01 CA163591NIAID NIH HHS R01 AI097382Wellcome Trust
6 · The paper itself

Abstract

The pentose phosphate pathway (PPP) is a fundamental component of cellular metabolism. The PPP is important to maintain carbon homoeostasis, to provide precursors for nucleotide and amino acid biosynthesis, to provide reducing molecules for anabolism, and to defeat oxidative stress. The PPP shares reactions with the Entner-Doudoroff pathway and Calvin cycle and divides into an oxidative and non-oxidative branch. The oxidative branch is highly active in most eukaryotes and converts glucose 6-phosphate into carbon dioxide, ribulose 5-phosphate and NADPH. The latter function is critical to maintain redox balance under stress situations, when cells proliferate rapidly, in ageing, and for the 'Warburg effect' of cancer cells. The non-oxidative branch instead is virtually ubiquitous, and metabolizes the glycolytic intermediates fructose 6-phosphate and glyceraldehyde 3-phosphate as well as sedoheptulose sugars, yielding ribose 5-phosphate for the synthesis of nucleic acids and sugar phosphate precursors for the synthesis of amino acids. Whereas the oxidative PPP is considered unidirectional, the non-oxidative branch can supply glycolysis with intermediates derived from ribose 5-phosphate and vice versa, depending on the biochemical demand. These functions require dynamic regulation of the PPP pathway that is achieved through hierarchical interactions between transcriptome, proteome and metabolome. Consequently, the biochemistry and regulation of this pathway, while still unresolved in many cases, are archetypal for the dynamics of the metabolic network of the cell. In this comprehensive article we review seminal work that led to the discovery and description of the pathway that date back now for 80 years, and address recent results about genetic and metabolic mechanisms that regulate its activity. These biochemical principles are discussed in the context of PPP deficiencies causing metabolic disease and the role of this pathway in biotechnology, bacterial and parasite infections, neurons, stem cell potency and cancer metabolism.

Indexed as

HumansMetabolic DiseasesMetabolismPentose Phosphate Pathwaycancerglucose 6‐phosphate dehydrogenaseglycolysishost–pathogen interactionsinherited metabolic diseasemetabolic engineeringmetabolism of infectionmetabolomicsNADPHoxidative stressparasitic protozoapentose phosphate pathwaystem cells

Identifiers

PMID25243985
PMCPMC4470864
OpenAlexW1673751863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.